Abstract
ACROSS 1 These dialysis membranes clear 10–20 kDa solutes and have a pore size of 3–6 nm. (8) 3 Low concentrations of potassium and ____ have been associated with sudden cardiac death in dialysis patients. (7) 8 This alternate form of anticoagulation on hemodialysis has been speculated to worsen secondary hyperparathyroidism. (7) 10 This large randomized trial showed that statins had no reduction in either overall or cardiovascular mortality in patients with chronic kidney disease who reached end-stage renal disease. (5) 12 In the Frequent Hemodialysis Network trial that looked at in-center hemodialysis six times per week versus three times per week, the group that had more frequent dialysis had more ___ related complications. (6) 13 After initiating dialysis, the mortality is the highest in the first ___ weeks. (3) 14 This uremic toxin is toxic to endothelium and leads to vasculogenesis. (12) DOWN 1 ____ impairs the absorption and recycling of iron and inhibits the proliferation of erythroid progenitor cells. (8) 2 This landmark trial showed that patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane. (4) 4 Frequency ____ of dialysis and membrane type are important considerations for removal of low-molecular-weight uremic toxins. (6) 5 Low ____ concentrations have been shown to be associated with symptomatic or asymptomatic intradialytic hypotension. (9) 6 Based on the European Best Practice Guidelines, the minimum frequency and dose of dialysis is ___ hours per treatment three times per week for most patients. (4) 7 Relative plasma volume may be a useful technique to assess __ _____ among hypertensive hemodialysis patients. (9) 9 The most common cause of end-stage kidney disease in the United States. (8) 11 Dialysate ____ is a potential culprit substance that leads to intradialytic hypotension. (7) 12 This uremic protein-bound toxin reduces nitric oxide synthesis and provokes an increase in systemic vascular resistance and hypertension. (Abbrv) (4) http://www.kidney-international.org m a k e y o u r d i a g n o s i s
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.